Regulatable gene expression systems for gene therapy

Current Gene Therapy

Volumn 6, Issue 4, 2006, Pages 421-438

  Vilaboa, Nuria ^a   Voellmy, Richard ^b,c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c HSF Pharmaceuticals SA   (Switzerland)

Author keywords

Gene switch; Gene therapy; Spatial regulation; Temporal regulation; Transcriptional targeting

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; DOXYCYCLINE; EARLY GROWTH RESPONSE FACTOR 1; ECDYSTEROID; EPIDERMAL GROWTH FACTOR; FAS LIGAND; FK 506 BINDING PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOSOME; LUCIFERASE; MIFEPRISTONE; PROSTAGLANDIN; PROTEIN C FOS; PROTEIN C JUN; RAPAMYCIN; RECEPTOR; REPRESSOR PROTEIN; TACROLIMUS; TAMOXIFEN; TETRACYCLINE; THYMIDINE KINASE; TNFERADE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CLINICAL TRIAL; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE INDUCTION; GENE SWITCHING; GENE THERAPY; HEAT; HUMAN; INSECT; MAMMAL; NONHUMAN; PROMOTER REGION; RADIATION; REPRESSOR GENE; REVIEW; STIMULATION; TRANSGENE;

ANIMALS; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMANS;

BACTERIA (MICROORGANISMS); INSECTA; MAMMALIA;

EID: 33746921625     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306777934829     Document Type: Review

References (141)

1. Abraham, R.T. (1998) Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine recepetor signaling. Curr. Opin. Immunol., 10: 330-336.
2. Abruzzese, R.V., Godin, D., Mehta, V., Perrard, J.L., French, M., Nelson, W., Howell, G., Coleman, M., O'Malley, B.W., Nordstrom, J.L. (2000) Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based, autoinducible Gene-Switch system. Mol. Ther., 2: 276-287.
3. Auricchio, A., Gao, G.P., Yu, Q.C., Raper, S., Rivera, V.M., Clackson, T., Wilson, J.M. (2002a) Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Ther., 9: 963-971.
4. Auricchio, A., Rivera, V.M., Clackson, T., O'Connor, E.E., Maguire, A.M., Tolentino, M.J. Bennett, J., Wilson, J.M. (2002b) Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther., 6: 238-242.
5. Babij, P., Psaltis, G., Song, D., Kulik, J., Mollova, N., Abruzzese, R.V., Nordstrom, J.L. (2003) "Blue heart": characterization of a mifepristone-dependent system for conditional gene expression in genetically modified animals. Biochim. Biophys Acta, 1627: 15-25.
6. Bajramovic, J.J., Bsibsi, M., Geutskens, S.B., Hassankhan, R., Verhulst, K.C., Stege, G.J., de Groot, C.J., van Noort, J.M. (2000) Differential expression of stress proteins in human adult astrocytes in response to cytokines. J. Neuroimmunol., 106: 14-22.
7. Barde, I., Zanta-Boussif, M.A., Paisant, S., Leboeuf, M., Rameau, P., Delenda, C., Danos, O. (2006) Efficient control of gene expression in the hematopoietic system using a single tet-on inducible lentiviral vector. Mol. Ther., 13: 382-390.
8. Baron, U., Gossen, M., Bujard, H. (1997) Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res., 25: 2723-2729.
9. Baron, U., Schnappinger, D., Helbl, V., Gossen, M., Hillen, W., Bujard, H. (1999) Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc. Natl. Acad. Sci. USA, 96: 1013-1018.
10. Bateman, A., Bullough, F., Murphy, S., Emiliusen, L., Lavillette, D., Cosset, F.L., Cattaneo, R., Russell, S.J., Vile, R.G. (2000). Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res., 60: 1492-1497.
11. Beck, C., Uramoto, H., Boren, J., Akyurek, L.M. (2004) Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges. Curr. Gene Ther., 4: 457-467.
12. Benjamin, I.J., Kroger, B., Williams, R.S. (1990) Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc. Natl. Acad. Sci. USA, 87: 6263-6267.
13. Bo, J., Yu, W., Zhang, Y.M., Demayo, F.J., Wei, L. (2005) Cardiac-specific and ligand-inducible target gene expression in transgenic mice. J. Mol. Cell. Cardiol., 38: 685-691.
14. Bornkamm, G.W., Berens, C., Kuklik-Roos, C., Bechet, J.M., Laux, G., Bachl, J., Korndoerfer, M., Schlee, M., Holzel, M., Malamoussi, A., Chapman, R.D., Nimmerjahn, F., Mautner, J., Hillen, W., Bujard, H., Feuillard, J. (2005) Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res., 33: e137.
15. Brade, A.M., Ngo, D., Szmitko, P., Li, P.X., Liu, F.F., Klamut, H.J. (2000) Heat-directed gene targeting of adenoviral vectors to tumor cells. Cancer Gene Ther., 7: 1566-1574.
16. Brade, A.M., Szmitko, P., Ngo, D., Liu, F.F., Klamut, H.J. (2003) Heat-directed tumor cell fusion. Hum. Gene Ther., 14: 447-461.
17. Braiden, V., Ohtsuru, A., Kawashita, Y., Miki, F., Sawada, T., Ito, M., Cao, Y., Kaneda, Y., Koji, T., Yamashita, S. (2000) Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. Hum. Gene Ther., 11: 2453-2463.
18. Bramson, J.L., Hitt, M., Gauldie, J., Graham, F.L. (1997) Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther., 4: 1069-1076.
19. Burcin, M.M., Schiedner, G., Kochanek, S., Tsai, S.Y., O'Malley, B.W. (1999) Adenovirus-mediated regulable target gene expression in vivo. Proc. Natl. Acad. Sci. USA, 96: 355-360.
20. Burkhardt, B.R., Parker, M.J., Zhang, Y.C., Song, S., Wasserfall, C.H., Atkinson, M.A. (2005) Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. FEBS Lett., 579: 5759-5764.
21. Chastel, C., Jiricny, J., Jaussi, R. (2004) Activation of stress-responsive promoters by ionizing radiation for deployment in targeted gene therapy. DNA Repair, 3: 201-215.
22. Chong, H., Ruchatz, A., Clackson, T., Rivera, V.M., Vile, R.G. (2002) A system for small-molecule control of conditionally replication-competent adenoviral vectors. Mol. Ther., 5: 195-203.
23. Christians, E.S., Benjamin, I.J. (2006) Heat shock response: lessons from mouse knockouts. Handb. Exp. Pharmacol., 172: 139-152.
24. Chtarto, A., Bender, H.U., Hanemann, C.O., Kemp, T., Lehtonen, E., Levivier, M., Brotchi, J., Velu, T., Tenenbaum, L. (2003) Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther. 10: 84-94.
25. Clemons, P.A., Gladstone, B.G., Seth, A., Chao, E.D., Foley, M.A., Schreiber, S.L. (2002) Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors. Chem. Biol., 9: 49-61.
26. Cronin, C.A., Gluba, W., Scrable, H. (2001) The lac operator-repressor system is functional in the mouse. Genes & Dev., 15: 1506-1517.
27. Das, A.T., Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., Berkhout, B. (2004) Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J. Biol. Chem., 279: 18776-18782.
28. Diaz, R.M., Bateman, A., Emiliusen, L., Fielding, A., Trono, D., Russell, S.J., Vile, R.G. (2000) A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Ther., 7: 1656-1663.
29. Dreano, M., Brochot, J., Myers, A., Cheng-Meyer, C., Rungger, D., Voellmy, R., Bromley, P. (1986) High-level, heat-regulated synthesis of proteins in eukaryotic cells. Gene, 49: 1-8.
30. Freundlieb, S., Schirra-Muller, C., Bujard, H. (1999) A tetracycline-controlled activation/repression system with increased potential for gene transfer into mammalian cells. J. Gene Med., 1: 4-12.
31. Furth, P.A., St Onge, L., Boger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., Hennighausen, L. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA, 91: 9302-9306.
32. Fussenegger, M., Morris, R.P., Fux, C., Rimann, M., von Stockar, B., Thompson, C.J., Bailey, J.E. (2000) Streptogramin-based gene regulation systems for mammalian cells. Nat. Biotechnol., 18: 1203-1208.
33. Fux, C. Weber, W., Daoud-el Baba, M., Heinzen, C., Aubel, D., Fussenegger, M. (2003) Novel macrolide-adjustable bidirectional expression modules for coordinated expression of two different transgenes in mice. J. Gene Med., 5: 1067-1079.
34. Galimi, F., Saez, E., Gall, J., Hoong, N., Cho, G., Evans, R.M., Verma, I.M. (2005) Development of ecdysone-regulated lentiviral vectors. Mol. Ther., 11: 142-148.
35. Go, W.Y., Ho, S.N. (2002) Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems. J. Gene Med., 4: 258-270.
36. Gossen, M., Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551.
37. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science, 268: 1766-1769.
38. Gould, D.J., Chernajovsky, Y. (2004) Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline system. Mol. Ther., 10: 127-138.
39. Greco, O., Joiner, M.C., Doleh, A., Powell, A.D., Hillman, G.G., Scott, S.D. (2006) Hypoxia- and radiation-activated Cre/loxP "molecular switch" vectors for gene therapy of cancer. Gene Ther., 13: 206-215.
40. Guilhon, E., Voisin, P., de Zwart, J.A., Quesson, B., Salomir, R., Maurange, C., Bouchaud, V., Smirnov, P., de Verneuil, H., Vekris, A., Canioni, P., Moonen, C.T.W. (2003) Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound. J. Gene Med., 5: 333-342.
41. Hallahan, D.E., Mauceri, H.J., Seung, L.P., Dunphy, E.J., Wayne, J.D., Hanna, N.N., Toledano, A., Hellman, S., Kufe, D.W., Weichselbaum, R.R. (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nat. Med., 1: 786-791.
42. Hillen, W., Wissman, A. (1989) "Topics in Molecular & Structural Biology, in Protein-Nucleic Acid Interaction: Tet repressor- tet operator interaction", Eds Saeger & Heinemann, MacMillan, London, 10: 143-162.
43. Hoppe, U.C., Marban, E., Johns, D.C. (2000) Adenovirus-mediated inducible gene expression in vivo by a hybrid ecdysone receptor. Mol. Ther., 1: 159-164.
44. Huang, Q., Hu, J.L., Lohr, F., Zhang, L., Braun, R., Lanzen, J., Little, J.B., Dewhirst, M.W., Li, C.Y. (2000) Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res., 60: 3435-3439.
45. Isomoto, H., Ohtsuru, A., Braiden, V., Iwamatsu, M., Miki, F., Kawashita, Y., Mizuta, Y., Kaneda, Y., Kohno, S., Yamashita, S. (2006) Heat-directed suicide gene therapy mediated by heat shock promoter for gastric cancer. Oncol. Rep., 15: 629-635.
46. Johnston, J., Tazelaar, J., Rivera, V.M., Clackson, T., Gao, G.P., Wilson, J.M. (2003) Regulated expression of erythropoietin from an AAV vector safely improves the anemia of β-thalassemia in a mouse model. Mol. Ther., 7: 493-497.
47. Kampinga, H.H. (2006) Chaperones in preventing protein denaturation in living cells and protecting against cellular stress. Handb. Exp. Pharmacol., 172: 1-42.
48. Karns, L.R., Kisielewski, A., Gulding, K.M., Seraj, J.M., Theodorescu, D. (2001) Manipulation of gene expression by an ecdysone-inducible gene switch in tumor xenografts. BMC Biotechnol., 1: 11.
49. Karzenowski, D., Potter, D.W., Padidam, M. (2005) Inducible control of transgene expression with ecdysone receptor: gene switches with high sensitivity, robust expression, and reduced size. Biotechniques, 39: 191-192.
50. Kawashita, Y., Ohtsuru, A., Kaneda, Y., Nagayama, Y., Kawazoe, Y., Eguchi, S., Kuroda, H., Fujioka, H., Ito, M., Kanematsu, T., Yamashita, S. (1999) Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation. Hum. Gene Ther., 10: 1509-1519.
51. Kumar, M.B., Fujimoto, T., Potter, D.W., Deng, Q., Palli, S.R. (2002) A single point mutation in ecdysone receptor leads to increased ligand specificity: implications for gene switch applications. Proc. Natl. Acad. Sci. USA, 99: 14710-14715.
52. Kumar, M.B., Potter, D.W., Hormann, R.E., Edwards, A., Tice, C.M., Smith, H.C., Dipietro, M.A., Polley, M., Lawless, M., Wolohan, P.R., Kethidi, D.R., Palli S.R. (2004) Highly flexible ligand binding pocket of ecdysone receptor: a single amino acid change leads to discrimination between two groups of nonsteroidal ecdysone agonists. J. Biol. Chem., 279: 27211-27218.
53. Lamartina, S., Silvi, L., Roscilli, G., Casimiro, D., Simon, A.J., Davies, M.E., Shiver, J.W., Rinaudo, C.D., Zampaglione, I., Fattori, E., Colloca, S., Gonzalez Paz, O., Laufer, R., Bujard, H., Cortese, R., Ciliberto, G., Toniatti, C. (2003) Construction of an rtTA2(s)-m2/ tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates. Mol. Ther., 7: 271-280.
54. Lebherz, C., Auricchio, A., Maguire, A.M., Rivera, V.M., Tang, W., Grant, R.L., Clackson, T., Bennett, J., Wilson, J.M. (2005) Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. Hum. Gene Ther., 16: 178-186.
55. Lo, H.W., Day, C.P., Hung, M.C. (2005) Cancer-specific gene therapy. Adv. Genet., 54: 235-255.
56. Locke, M., Noble, E.G., Tanguay, R.M., Field, M.R., Ianuzzo, S.E., Ianuzzo, C.D. (1995) Activation of heat-shock factor in rat heart after heat shock and exercise. Am. J. Physiol., 268: C1387-C1394.
57. Luce, M.J., Reiser, J. (2002) Development of regulated lentiviral vectors. Mol. Ther., 5: S32.
58. Lutucuta, S., Tsybouleva, N., Ishiyama, M., Defreitas, G., Wei, L., Carabello, B., Marian, A.J. (2004) Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice. J. Am. Coll. Cardiol., 44: 2221-2230.
59. Magari, S.R., Rivera, V.M., Iuliucci, J.D., Gilman, M., Cerasoli, F. Jr. (1997) Pharmacologic control of a humanized gene therapy system implanted into nude mice. J. Clin. Invest., 100: 2865-2872.
60. Manome, Y., Kunieda, T., Wen, P.Y., Koga, T., Kufe, D.W., Ohno, T. (1998) Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the EGR-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum. Gene Ther., 9: 1409-1417.
61. Marignol, L., Lawler, M., Coffey, M., Hollywood, D. (2005) Achieving hypoxia-inducible gene expression in tumors. Cancer Biol. Ther., 4: 359-364.
62. Markusic, D., Oude-Elferink, R., Das, A.T., Berkhout, B., Seppen, J. (2005) Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res., 33: e63.
63. Marples, S.B., Scott, S.D., Hendry, J.H., Embleton, M.J., Lashford, L.S., Margison, G.P. (2000) Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther., 7: 511-517.
64. Marr, R.A., Hitt, M., Muller, W.J., Gauldie, J., Graham, F.L. (1998) Tumour therapy in mice using adenovirus vectors expressing human TNFa. Int. J. Oncol., 12: 509-515.
65. Marr, R.A., Hitt, M., Gauldie, J., Muller, W.J., Graham, F.L. (1999) A p75 tumor necrosis factor receptor-specific mutant of murine tumor necrosis factor alpha expressed from an adenovirus vector induces an antitumor response with reduced toxicity. Cancer Gene Ther., 6: 465-474.
66. Matsumoto, T., Kiguchi, K., Jiang, J., Carbajal, S., Ruffino, L., Beltran, L., Wang, X.J., Roop, D.R., DiGiovanni, J. (2004) Development of transgenic mice that inducibly express an active form of c-Src in the epidermis. Mol. Carcinog., 40: 189-200.
67. Mauceri, H.J., Hanna, N.N., Wayne, J.D., Hallahan, D.E., Hellman, S., Weichselbaum, R.R. (1996) Tumor necrosis factor alpha (TNF alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res., 56: 4311-4314.
68. Mauceri, H.J., Hanna, N.N., Beckett, M.A., Gorski, D.H., Staba, M.J., Stellato, K.A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G.A., Sukhatme, V.P., Kufe, D.W., Weichselbaum, R.R. (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature, 394: 287-291.
69. McCormick, F. (2003) Cancer-specific viruses and the development of ONYX-015. Cancer Biol. Ther., 2: S157-160.
70. Mehta, H.B., Popovich, B.K., Dillmann, W.H. (1988) Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ. Res., 63: 512-517.
71. Melo, L.G., Gnecchi, M., Pachori, A.S., Kong, D., Wang, K., Liu, X., Pratt, R.E., Dzau, V.J. (2004) Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Artherioscler. Thromb. Vasc. Biol., 24: 1761-1774.
72. Mezhir, J.J., Smith, K.D., Posner, M.C., Senzer, N., Yamini, B., Kufe, D.W., Weichselbaum, R.R. (2006) Ionizing radiation: a genetic switch for cancer gene therapy. Cancer Gene Ther., 13: 1-6.
73. Mitta, B., Weber, C.C., Fussenegger, M. (2005) In vivo transduction of HIV-1-derived lentiviral particles engineered for macrolide-adjustable transgene expression. J. Gene Med., 7: 1400-1408.
74. Mizuguchi, H., Xu, Z.L., Sakurai, F., Mayumi, T., Hayakawa, T. (2003) Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum. Gene Ther., 14: 1265-1277.
75. Moseley, P.L. (1998) Heat shock proteins and the inflammatory response. Ann. N.Y. Acad. Sci., 856: 206-213.
76. Multhoff, G. (2006) Heat shock proteins in immunity. Handb. Exp. Pharmacol., 172: 279-304.
77. Mundt, A.J., Vijayakumar, S., Nemunaitis, J., Sandler, A., Schwartz, H., Hanna, N., Peabody, T., Senzer, N., Chu, K., Rasmussen, C.S., Kessler, P.D., Rasmussen, H.S., Warso, M., Kufe, D.W., Gupta, T.D., Weichselbaum, R.R. (2004) A phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities. Clin. Cancer Res., 10: 5747-5753.
78. Ngan, E.S., Ma, Z.Q., Chua, S.S., DeMayo, F.J., Tsai, S.Y. (2002) Inducible expression of FGF-3 in mouse mammary gland. Proc. Natl. Acad. Sci. USA, 99: 11187-11192.
79. No, D., Yao, T.P., Evans, R.M. (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA, 93: 3346-3351.
80. Nordstrom, J.L. (2002) Antiprogestin-controllable transgene regulation in vivo. Curr. Opin. Biotechnol., 13: 453-458.
81. Oehme, I., Bosser, S., Zornig, M. (2006) Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. Cell Death Differ., 13: 189-201.
82. Oligino, T., Poliani, P.L., Wang, Y., Tsai, S.Y., O'Malley, B.W., Fink, D.J., Glorioso, J.C. (1998) Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther., 5: 491-496.
83. Palli, S.R., Kapitskaya, M.Z., Kumar, M.B., Cress D.E. (2003) Improved ecdysone receptor-based inducible gene regulation system. Eur. J. Biochem., 270: 1308-1315.
84. Palli, S.R., Kapitskaya, M.Z., Potter, D.W. (2005) The influence of heterodimer partner ultraspiracle/retinoid X receptor on the function of ecdysone receptor. FEBS J., 272: 5979-5990.
85. Pierson, T.M., Wang, Y., DeMayo, F.J., Matzuk, M.M., Tsai, S.Y., O'Malley, B.W. (2000) Regulable expression of inhibin A in wild-type and inhibin alpha null mice. Mol. Endocrinol., 14: 1075-1085.
86. Pollock, R., Issner, R., Zoller, K., Nateson, S., Rivera, V.M., Clackson, T. (2000) Delivery of a stringent, dimerizer-regulated gene expression system in a single retroviral vector. Proc. Natl. Acad. Sci. USA, 97: 13221-13226.
87. Pollock, R., Clackson, T. (2002) Dimerizer-regulated gene expression. Curr. Opin. Biotechnol., 13: 459-467.
88. Pomerantz, J.L., Sharp, P.A., Pabo, C.O. (1995) Structure-based design of transcription factors. Science, 267: 93-96.
89. Rang, A., Will, H. (2000) The tetracycline-responsive promoter contains functional interferon-inducible response elements. Nucleic Acids Res., 28: 1120-1125.
90. Rivera, V.M., Clackson, T., Nateson, S., Pollock, R., Amara, J.F., Keenan, T., Magari, S.R., Phillips, T., Courage, N.L., Cerasoli, F. Jr., Holt, D.A., Gilman, M. (1996) A humanized system for pharmacologic control of gene expression. Nat. Med., 2: 1028-1032.
91. Rivera, V.M., Ye, X., Courage, N.L., Sachar, J., Cerasoli, F. Jr., Wilson, J.M., Gilman, M. (1999) Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc. Natl. Acad. Sci. USA, 96: 8657-8662.
92. Rivera, V.M., Gao, G.P., Grant, R.L., Schnell, M.A., Zoltick, P.W., Rozamus, L.W., Clackson, T., Wilson, J.M. (2005) Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood, 105: 1424-1430.
93. Roberts, M. (2002) Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim and sulfonamide drug classes. Mol. Biotechnol., 20: 261-284.
94. Rome, C., Couillaud, Moonen, C.T.W. (2005). Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters. Methods, 35: 188-198.
95. Roscilli, G., Rinaudo, C.D., Cimino, M., Sporeno, E., Lamartina, S., Ciliberto, G., Toniatti, C. (2002) Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor. Mol. Ther., 6: 653-663.
96. Rubinchik, S., Woraratanadharm, J., Yu, H., Dong, J.Y. (2005) New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo. Gene Ther., 12: 504-511.
97. Ryan, A., Scrable, H. (2004) Visualization of the dynamics of gene expression in the living mouse. Mol. Imaging, 3: 33-42.
98. Saez, E., Nelson, M.C., Eshelman, B., Banayo, E., Koder, A., Cho, G.J., Evans, R.M. (2000) Identification of ligands and coligands for the ecdysone-regulated gene switch. Proc. Natl. Acad. Sci. USA. 97: 14512-14517.
99. Salminen, W.F., Jr, Voellmy, R., Roberts, S.M. (1997) Differential heat shock protein induction by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver. J. Pharmacol. Exp. Ther., 282: 1533-1540.
100. Salucci, V., Scarito, A., Aurisicchio, L., Lamartina, S., Nicolaus, G., Giampaoli, S., Gonzalez-Paz, O., Toniatti, C., Bujard, H., Hillen, W., Ciliberto, G., Palombo, F. (2002) Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther., 9: 1415-1421.
101. Sarkar, N.N. (2002) Mifepristone: bioavailability, pharmacokinetics, and use-effectiveness. Eur. J. Obstet. Gynecol. Reprod. Biol., 101: 113-120.
102. Scheibel, T., Buchner, J. (2006) Protein aggregation as a cause for disease. Handb. Exp. Pharmacol., 172: 199-219.
103. Schiller, P., Amin, J., Ananthan, J., Brown, M.E., Scott, W.A., Voellmy, R. (1988) Cis-acting elements involved in the regulated expresion of a human hsp70 gene. J. Mol. Biol., 203: 97-105.
104. Schillinger, K.J., Tsai, S.Y., Taffet, G.E., Reddy, A.K., Marian, A.J., Entman, M.L., Oka, K., Chan, L., O'Malley, B.W. (2005) Regulatable atrial natriuretic peptide gene therapy for hypertension. Proc. Natl. Acad. Sci. USA, 102: 13789-13794.
105. Scott, S.D., Marples, B., Hendry, J.H., Lashford, L.S., Embleton, M.J., Hunter, R.D., Howell, A., Margison, G.P. (2000) A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther., 7: 1121-1125.
106. Senzer, N., Mani, S., Rosemurgy, A., Nemunaitis, J., Cunningham, C., Guha, C., Bayol, N., Gillen, M., Chu, K., Rasmussen, C., Rasmussen, H., Kufe, D., Weichselbaum, R., Hanna, N. (2004) TNFerade biologic, an adenovector with a radiation-indicible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J. Clin. Oncol., 22: 592-601.
107. Seung, L.P., Mauceri, H.J., Beckett, M.A., Hallahan, D.E., Hellman, S., Weichselbaum, R.R. (1995) Genetic radiotherapy overcomes tumor resistance to cytotoxic agents. Cancer Res., 55: 5561-5565.
108. Shastry, S., Toft, D.O., Joyner, M.J. (2002) Hsp70 and Hsp90 expression in leucocytes after exercise in moderately trained humans. Acta Physiol. Scand., 175: 138-146.
109. Smith, R.C., Machluf, M., Bromley, P., Atala, A., Walsh, K. (2002) Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo. Hum. Gene Ther., 13: 697-706.
110. Su, H., Joho, S., Huang, Y., Barcena, A., Arakawa-Hoyt, J., Grossman, W., Kan, Y.W. (2004) Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc. Natl. Acad. Sci. USA, 101: 16280-16285.
111. Suhr, S.T., Gil, E.B., Senut, M.C., Gage, F.H. (1998) High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor. Proc. Natl. Acad. Sci. USA, 95: 7999-8004.
112. Thomas, H.E., Stunnenberg, H.G., Stewart, A.F. (1993) Heterodimerization of the Drosophila ecdysone receptor with retinoid X receptor and ultraspiracle. Nature, 362: 471-475.
113. Toniatti, C., Bujard, H., Cortese, R., Ciliberto, G. (2004) Gene therapy progress and prospects: transcription regulatory systems. Gene Ther., 11: 649-657.
114. Urlinger, S., Baron, U., Thellmann, M., Hasan, M.T., Bujard, H., Hillen, W. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA, 97: 7963-7968.
115. Vegeto E., Allan G.F., Schrader, W.T., Tsai, M.J., McDonnell, D.P., O'Malley, B.W. (1992) The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell, 69: 703-713.
116. Vekris, A., Maurange, C., Moonen, C., Mazurier, F., De Verneuil, H., Canioni, P., Voisin, P. (2000) Control of transgene expression using local hyperthermia in combination with a heat-sensive promoter. J. Gene Med., 2: 89-96.
117. Venkataseshan, V.S., Marquet, E. (1996) Heat shock protein 72/73 in normal and diseased kidneys. Nephron, 73: 442-449.
118. Vilaboa, N., Fenna, M., Munson, J., Roberts, S.M., Voellmy, R. (2005) Novel gene switches for targeted and timed expression of proteins of interest. Mol. Ther., 12: 290-298.
119. Voellmy, R., Ahmed, A., Schiller, P., Bromley, P., Rungger, D. (1985) Isolation and functional analysis of a human 70,000 dalton heat shock protein gene segment. Proc. Natl. Acad. Sci. USA, 82: 4949-4953.
120. Voellmy, R. (2006) Feedback regulation of the heat shock response. Handb. Exp. Pharmacol., 172: 43-68.
121. Wang, Y., O'Malley, B.W. Jr, Tsai, S.Y., O'Malley, B.W. (1994) A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA, 91: 8180-8184.
122. Wang, Y., Xu, J., Pierson, T., O'Malley, B.W., Tsai, S.Y. (1997a) Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator. Gene Ther., 4: 432-441.
123. Wang, Y., DeMayo, F.J., Tsai, S.Y., O'Malley, B.W. (1997b) Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat. Biotechnol., 15: 239-243.
124. Wang, S., Petravicz, J., Breakefield, X.O. (2003) Single HSV-amplicon vector mediates drug-induced gene expression via dimerizer system. Mol. Ther., 7: 790-800.
125. Wang, L., Hernandez-Alcoceba, R., Shankar, V., Zabala, M., Kochanek, S., Sangro, B., Kramer, M.G., Prieto, J., Qian, C. (2004) Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer. Gastroenterology, 126: 278-289.
126. Weber, W., Fux, C., Daoud-el Baba, M., Keller, B., Weber, C.C., Kramer, B.P., Heinzen, C., Aubel, D., Bailey, J.E., Fussenegger, M. (2002a) Macrolide-based transgene control in mammalian cells and mice. Nat. Biotechnol., 20: 901-907.
127. Weber, W., Kramer, B.P., Fux, C., Keller, B., Fussenegger, M. (2002b) Novel promoter/transactivator configurations for macroloide- and streptogramin-responsive transgene expression in mammalian cells. J. Gene Med., 4: 676-686.
128. Weichselbaum, R.R., Hallahan, D.E., Sukhatme, V.P., Kufe, D.W. (1992) Gene therapy targeted by ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys., 24: 565-567.
129. Weichselbaum, R.R., Kufe, D.W., Hellman, S., Rasmussen, H.S., King, C.R., Fischer, P.H., Mauceri, H.J. (2002). Radiation-induced tumor necrosis factor-expression: clinical application of physical and transcriptional targeting of gene therapy. Lancet Oncol., 3: 665-671.
130. Winklhofer, K.F., Tatzelt, J. (2006) The role of chaperones in Parkinson's disease and prion diseases. Handb. Exp. Pharmacol., 172: 221-258.
131. Worthington, J., Robson, T., Murray, M., O'Rourke, M. Keilty, G., Hirst, D.G. (2000) Modification of vascular tone using inos under the control of aradiation-inducible promoter. Gene Ther., 7: 1126-1131.
132. Wyborski, D.L., Bauer, J.C., Vaillancourt, P. (2001) Bicistronic expression of ecdysone-inducible receptors in mammalian cells. Biotechniques, 31: 618-20.
133. Xiong, W., Goverdhana, S., Sciascia, S.A., Candolfi, M., Zirger, J.M., Barcia, C., Curtin, J.F., King, G.D., Jaita, G., Liu, C., Kroeger, K., Agadjanian, H., Medina-Kauwe, L., Palmer, D., Ng, P., Lowenstein, P.R., Castro, M.G. (2006) Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J. Virol., 80: 27-37.
134. Xu, Z.L., Mizuguchi, H., Mayumi, T., Hayakawa, T. (2003) Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems. Gene, 309: 145-151.
135. Xu, L., Zhao, Y., Zhang, Q., Li, Y., Xu, Y. (2004) Regulation of transgene expression in muscles by ultrasound-mediated hyperthermia. Gene Ther., 11: 894-900.
136. Yao, T.P., Segraves, W.A., Oro, A.E., McKeown, M., Evans, R.M. (1992) Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell, 71: 63-72.
137. Yao, T.P., Forman, B.M., Jiang, Z., Cherbas, L., Chen, J.D., McKeown, M., Cherbas, P., Evans R.M. (1993) Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature, 366: 476-479.
138. Ye, X., Rivera, V.M., Zoltick, P., Cerasoli, F. Jr., Schnell, M.A., Gao, G., Hughes, J.V., Gilman, M., Wilson, J.,M. (1999) Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science, 283: 88-91.
139. Zhao, B., Chua, S.S., Burcin, M.M., Reynolds, S.D., Stripp, B.R., Edwards, R.A., Finegold, M.J., Tsai S.Y., DeMayo, F.J. (2001) Phenotypic consequences of lung-specific inducible expression of FGF-3. Proc. Natl. Acad. Sci. USA, 98: 5898-5903.
140. Zhu, Z., Ma, B., Homer, R.J., Zheng, T., Elias, J.A. (2001) Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J. Biol. Chem., 276: 25222-25229.
141. Zou, J., Salminen, W.F., Roberts, S.M., Voellmy, R. (1998) Correlation between glutathione oxidation and trimerization of heat shock factor 1, an early step in the stress induction of the Hsp response. Cell Stress & Chaperones, 3: 130-141.